PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32578856-15	2020	CONCLUSION: NLRP3 could enhance resistance to gemcitabine via IL-1beta/EMT/Wnt/beta-catenin signaling, which suggested that NLRP3 antagonist CY-09 might be incorporated into gemcitabine treatment for TNBC.	CY5.5 cyanine dye	141-146	interleukin 1 alpha	Homo sapiens	62-70